Completed
Efficacy of Silymarin for Treatment of Acute Hepatitis In Egypt A Randomized, Double-Blinded, Controlled Trial
Led by University of Maryland, Baltimore · Updated on 2021-04-23
200
Participants Needed
N/A
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
The overall objective of this project is to assess whether Silymarin therapy shortens illness or prevents complications in patients with acute hepatitis. We will specifically compare responses in acute hepatitis patients treated with Silymarin to those given a control preparation of a vitamin supplements in a double blinded, randomized, placebo-controlled trial.
CONDITIONS
Brief Title
Efficacy of Silymarin for Acute Hepatitis
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here